Dakota Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Dakota Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,486	Closed	-$204K	–	751
2024 Q4	$204K	Buy	5,486 +1,322	+32%	+$60.5K	﹤0.01%	707
2024 Q3	$202K	Buy	+4,164	New	+$183K	﹤0.01%	690
2024 Q1	–	Sell	-4,910	Closed	-$304K	–	725
2023 Q4	$304K	Sell	4,910 -25	-0.5%	-$1.31K	0.01%	517
2023 Q3	$227K	Buy	4,935 +49	+1%	+$2.67K	0.01%	565
2023 Q2	$281K	Sell	4,886 -540	-10%	-$23.9K	0.01%	496
2023 Q1	$203K	Buy	+5,426	New	+$178K	0.01%	563

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dakota Wealth Management's AMPH Position: Q1 2025 in Review

Dakota Wealth Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 5,486 shares — an estimated $204K sold.

Dakota Wealth Management first reported a position in AMPH in Q1 2023 and held it in 6 quarters. The position peaked at $304K in Q4 2023. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

Dakota Wealth Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Dakota Wealth Management sold 5,486 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $204K.
Dakota Wealth Management first reported a position in Amphastar Pharmaceuticals in Q1 2023 and held it in 6 quarters.
Dakota Wealth Management's Amphastar Pharmaceuticals position peaked at $304K in Q4 2023.
241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Dakota Wealth Management's 13F filing for Q1 2025, filed 2 May 2025.